ChemComm is publishing its 60th volume in 2024. Over the past 60 years, ChemComm has been the RSC’s most cited journal, and one of the most trusted venues for rapid publication of short communications. In our anniversary year, we recognise the important contributions ChemComm has made, and continues to make, in advancing the chemical sciences.
As part of our anniversary celebrations, we’ve brought together a collection featuring the latest research from some of our most loyal and dedicated authors. From those marking the beginning of their independent academic career by publishing their first article with us, to the rising stars and established leaders publishing in our yearly ‘Emerging Investigators’ and ‘Pioneering Investigators’ collections, this collection champions the contributions of our worldwide author community. We are proud many authors choose to support our journal by regularly publishing their best work with us. This collection also features papers from our ChemComm Emerging Investigator Lectureship winners, and our Outstanding Reviewer awardees, whose invaluable feedback has shaped our published content through the years.
To accompany the collection, we’ll be publishing interviews with contributing authors where they provide further insight into their research and reflect on their journey with ChemComm.
Check out our interview with Professor Shenyou Nie (Chongqing Medical University) below!
 |
Shenyou Nie was born in 1986 and received his BS degree (2009) from Wuhan University. He completed his PhD (2014) at Shanghai Institute of Organic Chemistry(SIOC, P. R.of China) under the supervision of Prof. Biao Yu. He then worked as a postdoctoral researcher at the labs of Prof. Arun K Ghosh(Purdue University, 2015-2016) and Prof. Yongcheng Song(Baylor College of Medicine, 2016-2020), respectively. He started his independent research at Chongqing Medical University in 2020. His research interests focus on the development of small molecule inhibitors and degraders targeting ferroptosis and cancer, and construction of diverse compound libraries based on employing Ugi reaction, photoredox catalysis and C-H activation/domino strategies. |
How have you seen ChemComm evolve over the years, and what aspects do you find most noteworthy?
ChemComm has drawn my great attention since I started my research in organic chemistry in 2009 as a first-year doctoral student. I was impressed by its consistent publishing the outstanding and significant research work across the chemical sciences worldwide. Thus, I feel excited to submit my first research work to ChemComm when I became an independent academic principal investigator.
What is your favourite thing about ChemComm?
The layout of the research article in ChemComm is my favorite. It is concise, clear, and straightforward, which could quickly draw the interest of the general reader.
In what ways do you think ChemComm stands out among other journals in your field?
In my opinion, I would like to say that ChemComm features a timely and efficient peer-review process with high-quality control.
How would you describe the peer review process and interaction with the editorial team at ChemComm?
During the peer-review process, the most impressive thing was the professional and thoughtful scientific questions raised by the editor and the reviewers, which significantly improved the quality of our paper. Moreover, the editorial team deals with the article rigorously and efficiently. In addition, the proofing of the article is very convenient.
Could you provide a brief summary of your recent ChemComm publication?
In 2023, our group published our first research work on ChemComm, which is a one-pot base-promoted post-Ugi 5-exo-dig “Conia-ene” type cyclization, enabling metal-free access to diverse 2,2-disubstituted 3-methyleneindoline derivatives under room temperature (Chem. Commun., 2023, 59, 3099-3102). We found that an intramolecular hydrogen bond plays a vital role for the Conia-ene type cyclization. Inspired by this key finding, we further developed a DBU-catalyzed post-Ugi amide-ester exchange and Conia-ene double cyclization reaction, facilitating the construction of bioactive benzo-fused spiroindolines in a “Green” fashion with significant anticancer activity (Chem. Commun., 2024, 60, 5455-5458).
Be sure to read the Communication, “Green synthesis for diverse bioactive benzo-fused spiroindolines through DBU-catalysed post-Ugi double cyclization” to learn more!
